|
Post by peppy on Jan 15, 2018 15:06:24 GMT -5
|
|
|
Post by mytakeonit on Jan 15, 2018 15:54:41 GMT -5
Okay peppy and brentie you got me ... yes, dementia is setting in. I think??? I can't remember ...
|
|
|
Post by bioexec25 on Jan 15, 2018 16:15:17 GMT -5
I miss Gilda also. I remember many of them. The Church Lady had some real classics. Phenomenal how many careers launched on SNL.
|
|
|
Post by mytakeonit on Jan 15, 2018 16:36:07 GMT -5
As the young crowd says ... "Who?"
|
|
|
Post by slugworth008 on Jan 15, 2018 16:46:13 GMT -5
I miss Gilda also. I remember many of them. The Church Lady had some real classics. Phenomenal how many careers launched on SNL. Always loved Eddy Murphy as Mister Robinson.
|
|
|
Post by bioexec25 on Jan 15, 2018 16:48:14 GMT -5
|
|
|
Post by babaoriley on Jan 15, 2018 18:00:00 GMT -5
It's staggering how much talent fed through that show. And don't you want to start your reply to some message board posts, with "Jane, you ignorant slut."
|
|
|
Post by digger on Jan 16, 2018 5:12:05 GMT -5
agreed zuegirdor, $1600 a month in todays US dollars is crazy. we need insurance. Peppy, I love you BUT why do you think Insurance Companies want to or will pay $1,600 per month when injected insulin is much cheaper? ? They don't. They won't. Afrezza is so far overpriced it's ridiculous. Cut the price of Afrezza SIGNIFICANTLY BELOW injected insulin and increase its Sales by three, four, five times or more! Make insurance companies our friends... by making Afrezza CHEAPER than Humalog and Novalog. I doubt cutting the price will help. Sanofi's apidra is 20% cheaper than either humalog or novolog, but it looks like it has insurance coverage on par with afrezza and prescription numbers that aren't that much better.
|
|
|
Post by pat on Jan 16, 2018 7:24:11 GMT -5
Sports - I do the same thing. Meant to respond yesterday.
|
|
|
Post by alethea on Jan 16, 2018 10:39:16 GMT -5
Peppy, I love you BUT why do you think Insurance Companies want to or will pay $1,600 per month when injected insulin is much cheaper? ? They don't. They won't. Afrezza is so far overpriced it's ridiculous. Cut the price of Afrezza SIGNIFICANTLY BELOW injected insulin and increase its Sales by three, four, five times or more! Make insurance companies our friends... by making Afrezza CHEAPER than Humalog and Novalog. Why do you think if this is the case that they haven’t done it? I talked to a rep who said the only thing that’ll help insurance is more patient demand. Then I talked to a real smart person over the weekend and he said the only thing that will help is the person they hired to do the negotiations with the insurance company’s. Really three different theory’s. Has anyone ever asked Mike? or has Mike ever talked about it? It makes sense that lowering the price would help, but I have no experience in this field at all. Has that worked before with other drugs? I am trying to repost as the previous attempt got screwed up with bad margins and was somewhat unreadable:I don't know. I guess they think Afrezza's superiority as an insulin will ultimately cause it to sell well, no matter how high the price. I think that thinking is a bad mistake. Your rep said they need more patient demand. Yeah, I completely agree. That's my point. Get some demand by making it more affordable. Make it more PROFITABLE for health insurance companies to have their customers using Afrezza rather than the injecteds. If that ever happens Afrezza will sell like hotcakes. I don't have specific examples of new drugs having their prices lowered. But look what a generic is doing to Lantus sales. Hurting them quite a bit. On a personal note, I suffer from Reflux. More than 10 years ago I was held hostage to Prilosec for about $140 month before it finally went generic. Now it is something like $15 per month. I don't know if the chapter is yet written as to whether Afrezza has improved insurance coverage very much for 2018. If coverage has not improved much, I think it is pretty obvious why. I don't get it. To me it's borderline insane to think insurance companies will pay more for A when they can put more dollars into their pockets with injecteds.
|
|
|
Post by thekid2499 on Jan 16, 2018 11:40:37 GMT -5
Alethea - I literally could not agree with you more. Your thoughts mirror mine.
|
|
|
Post by mnholdem on Jan 16, 2018 11:54:34 GMT -5
Moderator Note: The original post alethea is referring to has been removed.
|
|
|
Post by bthomas55ep on Jan 16, 2018 12:09:51 GMT -5
Thinking out loud here FWIW....Perhaps the high price, without consideration for the volume just yet, helps demonstrate margin to any potential partners at this point. If MNKD were currently giving it away so to speak, it may look less attractive to those that may be applying multiples to valuations. I have no idea if there is any rationale here, but thought I would throw this into the soup.
|
|
|
Post by casualinvestor on Jan 16, 2018 12:49:32 GMT -5
agreed zuegirdor, $1600 a month in todays US dollars is crazy. we need insurance. Peppy, I love you BUT why do you think Insurance Companies want to or will pay $1,600 per month when injected insulin is much cheaper? ? They don't. They won't. Afrezza is so far overpriced it's ridiculous. Cut the price of Afrezza SIGNIFICANTLY BELOW injected insulin and increase its Sales by three, four, five times or more! Make insurance companies our friends... by making Afrezza CHEAPER than Humalog and Novalog. Althea, you have much more experience with buying Afrezza than I do, but why is $1600/month being talked about? Earlier in this thread, we were talking about a price of $1600/script, and the high price of the script being from more people moving to 3-month scriptswww.goodrx.com/afrezza shows the "large" pack of 60 8u and 30 12u under $700 with coupon, and the "smaller pack" of 60 4u and 30 8u at ~$350 www.goodrx.com/novolog with 5 flexpens at about $550. I'm not sure which is a good comparison Insurance companies probably pay less.
|
|
|
Post by boca1girl on Jan 16, 2018 12:56:26 GMT -5
I remember vaguely Mike making some remark regarding lowering the price and how rebates to the Pharmacy Benefit Management Companies have a lot to do with covering drugs and the tier levels. Don’t quote me but I got the impression that a higher price would provide a larger profit for the middle men and therefore more favorable treatment with coverage. Sounds bassackwards, but the for profit medical system drives unexpected results.
|
|